Acorns Advisers’s Merck MRK Stock Holding History

Acorns Advisers’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$298K	Buy	2,479 +40	+2%	+$4.62K	﹤0.01%	89
2025 Q4	$257K	Sell	2,439 -10	-0.4%	-$939	﹤0.01%	93
2025 Q3	$206K	Buy	+2,449	New	+$202K	﹤0.01%	99

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acorns Advisers's MRK Position: Q1 2026 in Review

Acorns Advisers increased its Merck (MRK) stake by 1.6% in Q1 2026, buying an estimated $4.62K and bringing the position to 2,479 shares worth $298K. The position accounts for ﹤0.01% of the portfolio, ranked #89.

Acorns Advisers first reported a position in MRK in Q3 2025 and has held it in 3 quarters since. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Acorns Advisers held 2,479 shares of Merck worth $298K as of Q1 2026.
Acorns Advisers bought 40 Merck shares in Q1 2026, an estimated $4.62K.
Merck made up ﹤0.01% of Acorns Advisers's portfolio in Q1 2026, its #89 holding.
Acorns Advisers first reported a position in Merck in Q3 2025 and has held it in 3 quarters since.
3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Acorns Advisers's 13F filing for Q1 2026, filed 14 May 2026.